In patients with advanced pancreatic cancer, the serum concentration of C-reactive protein (CRP), a marker of systemic inflammation, was found to be positively correlated with those of sPD-1 and sPD-L1 (48), also supporting our hypothesis. This evidence concerns the gene SPDL1 and familial pancreatic carcinoma.